COST-EFFECTIVENESS ANALYSIS OF TELBIVUDINE VS LAMIVUDINE IN TREATING THE PATIENTS WITH HBEAG-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B IN CHINA

被引：0
|
作者：
Chen, W. [1 ]
Hou, J. [2 ]
机构：
[1] Fudan Univ, Shanghai 200433, Peoples R China
[2] So Med Univ, Guangzhou, Guangdong, Peoples R China
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75089-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A423 / A423
页数：1
相关论文
共 50 条
  • [1] Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis
    Banerjee, S.
    Gunda, P.
    Drake, R. F.
    Hamed, K.
    SPRINGERPLUS, 2016, 5
  • [2] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    D. Eldon Spackman
    David L. Veenstra
    PharmacoEconomics, 2008, 26 : 937 - 949
  • [3] Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
    He, Jing
    Bowen, James M.
    Xie, Feng
    Goeree, Ron
    VALUE IN HEALTH, 2012, 15 (06) : 894 - 906
  • [4] Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
    Wong, J. B.
    Pauker, S. G.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S199 - S199
  • [5] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    Spackman, D. Eldon
    Veenstra, David L.
    PHARMACOECONOMICS, 2008, 26 (11) : 937 - 949
  • [6] Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
    Wiens, Astrid
    Venson, Rafael
    Correr, Cassyano Januario
    Pontarolo, Roberto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (03): : 225 - 230
  • [7] COST-EFFECTIVENESS OF TELBIVUDINE IN FIRST LINE TREATMENT OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN THE TURKISH HEALTH CARE SETTING
    Pala, M.
    Sahin, U.
    VALUE IN HEALTH, 2011, 14 (07) : A276 - A276
  • [8] Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
    David L. Veenstra
    Sean D. Sullivan
    Lauren Clarke
    Uche H. Iloeje
    Eskinder Tafesse
    Adrian Di Bisceglie
    Kris V. Kowdley
    Robert G. Gish
    PharmacoEconomics, 2007, 25 : 963 - 977
  • [9] Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B
    Veenstra, David L.
    Sullivan, Sean D.
    Clarke, Lauren
    Iloeje, Uche H.
    Tafesse, Eskinder
    Di Bisceglie, Adrian
    Kowdley, Kris V.
    Gish, Robert G.
    PHARMACOECONOMICS, 2007, 25 (11) : 963 - 977
  • [10] Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and-Negative Chronic Hepatitis B
    Oyaguez, Itziar
    Buti, Maria
    Brosa, Max
    Rueda, Magdalena
    Casado, Miguel A.
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 358 - 365
12345